Report: DNA-based injections to fuel growth of animal vaccines market

U.K.-based Companies and Markets, an aggregator of market research, has released a report predicting the global market for animal vaccines will hit $7.2 billion by 2020--driven largely by DNA-based products. These vaccines stimulate the immune system not with the infectious agent itself, but rather with DNA encoding the antigens that prompt the desired immune response. DNA vaccines could offer many advantages, including improved stability and the ability to quickly scale up manufacturing. Several DNA vaccines are already on the market in animal health, including a product to prevent West Nile virus in horses. The report predicts that demand in both human and animal health will drive total sales of DNA-based vaccines from $305 million a year in 2014 to $2.7 billion by 2020. Article